Skip to main content
# Title Research Member Research Year
11 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Amen Hamdy Zaki Ali 2023
12 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Amany Nasr Ahmed Mohammed Elemary 2023
13 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Prof. Ashraf Zeidan Abdalla Ahmed 2023
14 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Amany Mohammed Abdel Moatamed 2023
15 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Prof. Ashraf Zeidan Abdalla Ahmed 2023
16 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Salah Mabrouk Khallaf Abd Rabou 2023
17 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Hossam El-Din / Mostafa Kamel Mohamed 2021
18 Laparoscopic versus Open Complete Mesocolic Excision for Right Colon Cancer Dr. Salah Mabrouk Khallaf Abd Rabou 2021
19 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Dr. Hanaan Ahmed Mohammed Ahmed 2021
20 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Ayat allah Ali yousseif 2021